drugset / Trial / NCT03077633

Cerclage for Twins With Short Cervix

NCT03077633

Phase 2/3 Withdrawn Pediatrix
RandomizedParallel-groupOpen-labelPrevention

Summary

A prospective randomized control trial that will compare cervical cerclage plus vaginal progesterone to vaginal progesterone along in twin pregnancies complicate by a short cervix (\</= 15.0mm) between 16w0d to 25w6d.

Timeline

Start
2017-10-01
Primary completion
2018-01-17
Completion
2018-01-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Other

Indications